PTSD
Conference Coverage
Four PTSD blood biomarkers identified
The biomarkers could be used to monitor treatment for PTSD, identify subtypes of PTSD, and lead to a new understanding of the mechanisms...
Conference Coverage
Impact of child abuse differs by gender
PARIS –
From the Journals
A new way to gauge suicide risk?
Social determinants of health are strong predictors of suicidal behaviors.
Commentary
Cultivating strength: Psychological well-being after nonfatal suicide attempts
People desire lives that they enjoy and find meaningful, and having a history of suicide attempts does not preclude the prospect of such a life....
Commentary
Clinician violence: Virtual reality to the rescue?
Workplace violence is affecting so many providers in hospital emergency departments but also throughout other parts of the hospital.
Conference Coverage
Mental health risks higher among young people with IBD
“Anxiety and depression will not be a surprise to most of us. But we also saw changes for eating disorders, PTSD, and sleep changes.”
From the Journals
Ketamine plus psychotherapy ‘highly effective’ for PTSD
A new study “demonstrates the potential feasibility of this treatment model and corroborates previous work.”
Commentary
More on psilocybin
I would like to remark on “Psychedelics for treating psychiatric disorders: Are they safe?” (Current Psychiatry, December 2022, p. 14-22, doi:10....
From the Journals
Two short-term exposure therapies linked to PTSD reductions
“This study provides important new evidence that combat-related PTSD can be effectively treated – in as little as 3 weeks,” said Dr. Alan Peterson...
From the Journals
Anxiety sensitivity fuels depression in dissociative identity disorder
Patients’ fear of cognitive anxiety symptoms contributes to dissociation through depression.
Latest News
More support for MDMA-assisted psychotherapy for PTSD
The full data from MAPP2 are expected to be published in a peer-reviewed journal later this year.